Lorenzo Gerratana

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Lorenzo Gerratana

Mar 3, 2025, 11:36 | Insight

Racial Disparities in ctDNA Profiles and Targeted Therapy in mBC - International Society of Liquid Biopsy

International Society of Liquid Biopsy (ISLB) shared a post on X about a paper by…

Dec 26, 2024, 15:50 | Insight

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…

Dec 22, 2024, 09:59 | Science

CDK4/6 inhibitors: mechanisms of resistance and where to find them - Lorenzo Gerratana

Lorenzo Gerratana, Associate Professor of Medicine at University of Udine, posted on X about recent…

Dec 13, 2024, 19:52 | Blog

Insights on EMBER3 trial from SABCS 2024

Imlunestrant has been approved for the treatment of breast cancer. It is a next-generation, brain-penetrant,…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023